BIO has unveiled a seven-part proposal aimed at accelerating drug development in the U.S. The plan is designed to counter China’s rapid advancements in the biotech sector.
The initiatives outlined in the proposal focus on enhancing the U.S. position as a global leader in biotechnology. Specific details of the initiatives were not provided in the draft.
This proposal may influence stakeholders in the biotech industry, particularly those involved in drug development and regulatory processes.
Source: biopharmadive.com · Image: Marine Sciences Laboratory at the Pacific Northwest National Laboratory by ENERGY.GOV, Public domain, via Wikimedia Commons
Planning your supply chain?
The API & FDF Intelligence database shows where manufacturers are located, which certificates they hold, and which markets are overheated.
With direct contacts for every supplier and holder, you can move from weeks of outreach to decisions made in hours.
Use the database as your supply chain compass →
Use the database as your supply chain compass →
